SEC Form 4 · accession 0001127602-15-000605
CUBIST PHARMACEUTICALS INC · CBST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Perez
Officer — Chief Executive Officer · Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 5, 2015 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000912183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2014 | J | 32 | $59.959 | A | 47,357 | D | |
| Common Stock | holding | — | — | — | 5,012 | I | 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | $0.00 | Jan 1, 2015 | A | 12,419 | A | Jan 1, 2016 | Jan 1, 2025 | Common Stock | 12,419 | 24,838 | D |
Explanation of responses
- F1Shares purchased pursuant to employee stock purchase plan
- F2Granted in connection with promotion to Chief Executive Officer on January 1, 2015.
- F3Option vests 6.25% quarterly over a four-year period.